- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19.12. | Universal Ibogaine Inc.: Universal Ibogaine Provides Bi-weekly Default Status Report on 2025 Year-end Filings and Update on Restructuring Process | 5 | TheNewswire | ||
| 03.12. | Universal Ibogaine Inc.: Universal Ibogaine advises further on application for Management Cease Trade Order | 8 | TheNewswire | ||
| 26.11. | Universal Ibogaine Inc: Universal Ibogaine applies for MCTO | 8 | Stockwatch | ||
| 25.11. | Universal Ibogaine Inc.: Universal Ibogaine Advises of Filing Application for Management Cease Trade Order | 4 | TheNewswire | ||
| 28.10. | Universal Ibogaine Inc: Universal Ibogaine "temporarily" closes Kelburn | 19 | Stockwatch | ||
| 28.10. | Universal Ibogaine Inc.: Universal Ibogaine Provides Corporate Update | 11 | TheNewswire | ||
| 24.09. | Universal Ibogaine Inc: Universal Ibogaine board lists five directors | 32 | Stockwatch | ||
| 23.09. | Universal Ibogaine Inc.: Universal Ibogaine Announces Board Changes | 11 | TheNewswire | ||
| UNIVERSAL IBOGAINE Aktie jetzt für 0€ handeln | |||||
| 15.09. | Universal Ibogaine Inc: Universal Ibogaine shareholders vote down two matters | 4 | Stockwatch | ||
| 15.09. | Universal Ibogaine Inc.: Universal Ibogaine Announces Results of the Annual Meeting of Shareholders | 15 | TheNewswire | ||
| 05.09. | Universal Ibogaine Inc. provides update on intent to file Clinical Trial Application with Health Canada and confirms securing of Ibogaine drug supply | 17 | TheNewswire | ||
| 04.09. | Universal Ibogaine Inc: Universal Ibogaine adds Killebrew, Wagner as directors | 14 | Stockwatch | ||
| 03.09. | Universal Ibogaine Inc.: Universal Ibogaine advises of appointment of two new Board Members | 4 | TheNewswire | ||
| 17.07. | Universal Ibogaine Inc: Universal Ibogaine CFO Leavens resigns | 10 | Stockwatch | ||
| 17.07. | Universal Ibogaine announces CFO departure | 13 | Seeking Alpha | ||
| 17.07. | Universal Ibogaine Inc.: Universal Ibogaine advises of departure of CFO | 3 | TheNewswire | ||
| 08.07. | Universal Ibogaine Inc: Universal Ibogaine director Cranwill resigns | 14 | Stockwatch | ||
| 08.07. | Universal Ibogaine Inc.: Universal Ibogaine Advises of Debt Settlement with CEO and Resignation of a Member of its Board of Directors | 5 | TheNewswire | ||
| 08.07. | Universal Ibogaine Inc: Universal Ibogaine 4,248,000 shares for debt | 2 | Stockwatch | ||
| 10.04. | XFRA JC4: WIEDERAUFNAHME/RESUMPTION | 362 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen |
1 2 Weiter >>
21 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SANOFI | 82,37 | -0,07 % | dpa-AFX-Überblick: UNTERNEHMEN vom 29.12.2025 - 15.15 Uhr | Energiekontor bestätigt Gewinnprognose für 2025 BREMEN - Der Entwickler und Betreiber von Wind- und Solarparks Energiekontor sieht sich dank Erfolge im Vertrieb sowie der Entwicklung seiner Wind-... ► Artikel lesen | |
| CANOPY GROWTH | 1,028 | +0,19 % | Nach der Trump-Unterschrift: Auch 2026 kein Ende der Leidenszeit? Canopy, Aurora, Tilray mit Kursbeben | © Foto: adobe.stock.comDie Spekulationen schossen ins Kraut, dass Trump eine Executive Order auf den Weg bringen würde, um den festgefahrenen Rescheduling-Prozess zu beschleunigen. Der Cannabis-Sektor... ► Artikel lesen | |
| ASTRAZENECA | 157,65 | +0,25 % | Jacobio, AstraZeneca ink cancer drug deal | ||
| INNOCAN PHARMA | 4,360 | +2,83 % | Innocan Pharma Corporation: Innocan Pharma Announces Public Filing of Amended Registration Statement for Proposed U.S. Public Offering | HERZLIYA, Israel and CALGARY, AB, Dec. 10, 2025 /PRNewswire/ -- Innocan Pharma Corporation ("Innocan" or the "Company") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that,... ► Artikel lesen | |
| ZOETIS | 107,10 | +0,04 % | Zoetis: P/E auf Allzeittief | Während Investoren verunsichert sind, zeigt ein Blick auf die Fundamentaldaten von Zoetis eine ganz andere Realität. Die Gewinne steigen unaufhörlich Den vollständigen Artikel lesen ... ► Artikel lesen | |
| IONIS PHARMACEUTICALS | 67,48 | -0,62 % | Ionis Pharmaceuticals, Inc.: TRYNGOLZA (olezarsen) approved in the European Union for familial chylomicronemia syndrome (FCS) | Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) and Sobi® today announced that TRYNGOLZA® (olezarsen) has been approved in the European Union (EU) as an adjunct to diet in adult patients for the treatment... ► Artikel lesen | |
| HAPPY BELLY FOOD GROUP | 1,310 | -4,38 % | Happy Belly Food Group Inc: Happy Belly signs LOI to sell Holy Crap Foods for $1M | ||
| CSPC PHARMA | 0,933 | +1,68 % | CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - POTENT ALDOSTERONE SYNTHASE INHIBITOR (SYH2072 TABLETS) OBTAINS CLINICAL TRIAL APPROVAL IN CHINA | ||
| ALTIMMUNE | 3,128 | +0,16 % | Altimmune, Inc: Altimmune Announces CEO Transition and Succession Plan | Jerry Durso, accomplished industry leader, to succeed Vipin Garg, Ph.D. as Chief Executive Officer Transition follows seven years of strong leadership by Dr. Garg GAITHERSBURG, Md., Dec. 01, 2025... ► Artikel lesen | |
| CATALYST PHARMACEUTICALS | 20,430 | -0,05 % | Catalyst Pharmaceuticals, Inc.: Catalyst Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update | Reported Q3 2025 Total Revenues of $148.4 Million, Driven by Continued FIRDAPSE® Growth, Strong AGAMREE® Uptake and Growth, and Continued Demand for FYCOMPA® Raising Full-Year 2025 Total Revenue Guidance... ► Artikel lesen | |
| AVADEL PHARMACEUTICALS | 18,300 | -0,54 % | Bank of America meldet Beteiligung von 2,37 % an Avadel Pharmaceuticals | ||
| NUMINUS WELLNESS | 0,027 | -100,00 % | Numinus Wellness Inc.: Numinus Wellness Provides Corporate Update | Vancouver, British Columbia--(Newsfile Corp. - December 1, 2025) - Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) ("Numinus" or the "Company"), a mental health care company focused on innovative... ► Artikel lesen | |
| ELANCO ANIMAL HEALTH | 19,200 | -0,21 % | Elanco Receives FDA Conditional Approval For Credelio Quattro CA1 To Treat Screwworm In Dogs | WASHINGTON (dpa-AFX) - Elanco Animal Health Incorporated (ELAN) on Thursday said it has received conditional approval from the U.S. Food and Drug Administration (FDA) for Credelio Quattro CA1... ► Artikel lesen | |
| ONO PHARMACEUTICAL | 11,400 | -1,72 % | Ono Pharmaceutical H1 Results Improve; Backs Annual Guidance | TOKYO (dpa-AFX) - Ono Pharmaceutical Co., Ltd.(OPHLF, 4528.T) on Thursday reported a rise in earnings and revenue for the first half. In addition, the company has reaffirmed its annual outlook.For... ► Artikel lesen | |
| IANTHUS CAPITAL | 0,001 | 0,00 % | iAnthus Capital Holdings, Inc.: iAnthus Reports Third Quarter 2025 Financial Results | NEW YORK and TORONTO, Nov. 12, 2025 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. ("iAnthus" or the "Company") (CSE: IAN, OTCID: ITHUF), which owns, operates, and partners with regulated cannabis... ► Artikel lesen |
Das Unternehmen UNIVERSAL IBOGAINE INC kann der Branche Pharma zugeordnet werden. Die relative Kursveränderung beträgt aktuell +66,67 % bei einem Aktienkurs von 0,005 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu UNIVERSAL IBOGAINE INC finden Sie auf Wallstreet Online.